VOYA Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,210
| Closed | -$1.4M | – | 2865 |
|
|
2024
Q2 | $1.4M | Buy |
34,210
+11,390
| +50% | +$466K | ﹤0.01% | 1450 |
|
|
2024
Q1 | $965K | Sell |
22,820
-41,224
| -64% | -$1.74M | ﹤0.01% | 1650 |
|
|
2023
Q4 | $2.72M | Buy |
64,044
+39,319
| +159% | +$1.67M | ﹤0.01% | 1252 |
|
|
2023
Q3 | $540K | Buy |
24,725
+264
| +1% | +$5.76K | ﹤0.01% | 1990 |
|
|
2023
Q2 | $778K | Buy |
24,461
+2,982
| +14% | +$94.8K | ﹤0.01% | 1830 |
|
|
2023
Q1 | $524K | Hold |
21,479
| – | – | ﹤0.01% | 2028 |
|
|
2022
Q4 | $677K | Buy |
21,479
+507
| +2% | +$16K | ﹤0.01% | 1856 |
|
|
2022
Q3 | $593K | Buy |
20,972
+496
| +2% | +$14K | ﹤0.01% | 1925 |
|
|
2022
Q2 | $541K | Buy |
20,476
+4,174
| +26% | +$110K | ﹤0.01% | 1787 |
|
|
2022
Q1 | $571K | Buy |
16,302
+593
| +4% | +$20.8K | ﹤0.01% | 1830 |
|
|
2021
Q4 | $509K | Buy |
15,709
+345
| +2% | +$11.2K | ﹤0.01% | 1997 |
|
|
2021
Q3 | $453K | Buy |
15,364
+1,342
| +10% | +$39.6K | ﹤0.01% | 2108 |
|
|
2021
Q2 | $359K | Buy |
+14,022
| New | +$359K | ﹤0.01% | 2288 |
|